Home » Headlines » Currently Reading:

Morning Headlines 1/31/25

January 30, 2025 Headlines No Comments

Khosla Ventures Backs UK Startup’s Plan to Bring Cancer AI Tool to US

UK-based startup C the Signs, which uses routinely collected EHR data to help primary care doctors detect 50 types of early-stage cancer, announces an $8 million investment from Khosla Ventures and plans to enter the US market.

Announcing MedSender’s Series A

AI medical assistant software startup MedSender raises $5 million in Series A funding.

23andMe Special Committee Announces Exploration of Strategic Alternatives

Once valued at $6 billion, genetic testing company 23andMe says that it is running out of cash and will try to find a buyer for the second time.

Kode Raises $27M in Series B Funding to Transform Medical Coding and Data Management

Kode Health, which operates a gig matching service for HIM coders and hospitals, raises $27 million in a Series B funding round.

HealthBus Expands Healthcare Solutions with Strategic Acquisition of BetterHealthcare

Employer-focused digital healthcare services and benefits integration company HealthBus acquires BetterHealthcare, which offers providers patient engagement software.



HIStalk Featured Sponsors

     

Text Ads


RECENT COMMENTS

  1. Weird that Google can acknowledge its crowdsourced medical advice was wrong, but escape penalties for doing it wantonly at scale.

  2. I'm a little curious about the possibility of this lawsuit having larger political rammifications. Texas and its AG have used…

  3. Re: Fischman v. Epic Systems Corporation Seems to me there's already a story to tell here. The case appears to…

  4. My theory is that Gallit is using the EHR case to try and get discovery to refile the Texas Health…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.